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The DNA binding activity of the transcriptional regulator
activator protein-1 shows considerable promise as a target in
cancer therapy. A number of different strategies have been
employed to inhibit the function of this protein with promise
having been demonstrated both in vitro and in vivo. Peptide-
based therapeutics have received renewed interest in the last few
years, and a number of 37-amino acid peptides capable of bind-
ing to the coiled coil dimerization domain of Jun and Fos have
been derived. Here, we demonstrate how truncation and semi-
rational library design, followed by protein-fragment comple-
mentation, can be used to produce a leucine zipper binding pep-
tide by iterative means. To this end, we have implemented this
strategy on the FosW peptide to produce 4hFosW. This peptide
is truncated by four residues with comparably favorable binding
properties and demonstrates the possibility to design progres-
sively shorter peptides to serve as leucine zipper antagonists
while retaining many of the key features of the parent peptide.
Whether or not the necessity for low molecular weight antago-
nists is required from the perspective of druggability and effi-
cacy is subject to debate. However, antagonists of reduced
length are worthy of perusal from the point of view of synthetic
cost as well as identifying the smallest functional unit that is
required for binding.
The basic region leucine zipper transcription factors are a
family of dimeric DNA-binding proteins containing a transac-
tivation domain, a DNA binding basic region, and a leucine
zipper region that mediates interaction of the two proteins.
Dimeric complexes of the Fos and Jun family combine to form
the transcriptional regulator, activator protein 1 (AP-1). AP-1
can be composed of a range of dimeric complexes (1) that have
an abundance of roles in gene regulation and tissue develop-
ment (2); however, their key universal function is in binding to
the 12-O-tetradecanoylphorbol-13-acetate (TPA)2-response
element (TRE) sequence (3) resulting in the activation of a
number of genes. However, pathological events can lead to the
overexpression of AP-1 causing unregulated proliferation or
differentiation and therefore cancer. This well established cen-
tral role in oncogenesis has positionedAP-1, which is one of the
final steps involved in signal transduction, as an exciting target
in cancer therapy (4). In particular, c-Jun has been widely stud-
ied andwas initially linked to cancer due to initial discovery as a
homologue of the v-Jun viral oncoprotein (5, 6). The leucine
zipper region that drives dimerization, and onwhich our antag-
onists are based, consists of supercoiled helices. These helices
interact such that there are 3.5 residues per turn in each helix,
so forming a heptad repeat (described by the nomenclature
abcdefg). In the heptad repeat a and d residues are found at the
dimer interface and provide a hydrophobic core. The a position
is found to contain a variety of hydrophobic residues (7) with
occasional selection of polar Asn/Lys residues to aid with spec-
ificity constraints (8), and the d positions are almost exclusively
restricted to Leu (9). Positions e and g form electrostatic inter-
helical contacts (10), which help to mediate specificity and are
thought to constitute a late folding event that predominantly
affects the dissociation rate of the complex (11). Finally, theb, c,
and f positions of the heptad repeat make up the backbone of
the coiled coil structure. These residues are positioned away
from the dimer interface and are thought to play a more subtle
role in coiled coil stability, for example by assisting with intra-
helical stability by forming electrostatic interactions between
flanking residues within the same helix and consequently, by
improving helical propensity as has been used in other coiled
coil design strategies (12).
To investigate the potential for reducing the size and length
of the peptide antagonist while retaining c-Jun-antagonist
interaction stability, we have performed a cycle of truncation of
the parent peptide, followed by re-randomization and screen-
ing of the library using a protein fragment complementation
approach.Wehave used the FosWas our framework for design,
which is a peptide that was previously selected to bind to c-Jun
with high affinity (Tm 63 °C) and that is based on the parallel
and dimeric wild-type Jun-Fos coiled coil interaction (13). The
work presented here will describe the rationale behind trunca-
tion of the parent peptide and the library design. In addition, we
will use a range of biophysical techniques to demonstrate that
the helices interact and will provide a measure of the affinity of
this interaction.
EXPERIMENTAL PROCEDURES
Library Design and Creation—Library design and cloning
have been described elsewhere (13–15). Briefly, megaprimers
were synthesized, including relevant degenerate codons for
library residue options, and a fill-in reaction was performed,
resulting in 111-bp double-stranded oligonucleotides. These
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were cloned via NheI and AscI sites into a pQE16 derivative
(Qiagen) containing a G/S linker tagged to fragment 1
(pES230d; library; ampicillin resistance (AmpR)) and fragment
2 (pES300d; c-Jun target chloramphenicol resistance (CmR)) of
murine DHFR, respectively, resulting in pES230d-4hFosW-li-
brary-DHFR1 and pES300d-c-Jun-DHFR2, respectively.
Winner Selection—The 4hFosW winner sequence was
selected by PCA from a 49,152 member library (see Fig. 1)
designed from the truncation of the final four residues of FosW
(13). The PCA protocol is described in detail elsewhere (8).
Briefly, the library and target peptides are genetically fused to
two halves of a split of murine dihydrofolate reductase (DHFR)
(16). Interaction between a library member and the target pep-
tide reconstitutes the DHFR activity (reduction of dihydrofo-
late and subsequent synthesis of nucleotides). This reconstitu-
tion of activity is relative to the interaction affinity. Therefore,
in media deficient in complex nutrients and containing tri-
methoprim (which selectively inhibits bacterial DHFR), only
those bacterial cells that contain a librarymember that interacts
with the target peptide will grow in the media. Transformed
cells containing library members with the highest interaction
affinity for the target protein will grow most rapidly and after
successive passages in liquidmediawill predominate in the bac-
terial pool. Expression of target and library proteins were under
control of a lac promoter, with expression induced using 1 mM
isopropyl -D-1-thiogalactopyranoside.
Confirmation ofWinner by Growth Curve Assay—Those col-
onies with the strongest antagonist-target interaction allowed
the most rapid growth under PCA conditions. Therefore, bac-
terial growth rates resulting from bacteria expressing 4hFosW
and c-Jun were compared with those expressing wild-type
c-Fos and c-Jun. Cell lines for this assay were prepared from
single colonies taken from plates under PCA conditions and
corresponded to the correctly sequenced plasmids.
Peptide Synthesis and Purification—Peptides were synthe-
sized by Protein Peptide Research Ltd. (Fareham, UK) and sub-
sequently purified to98% purity using RP-HPLC with a Jupi-
ter Proteo column (4-m particle size, 90-Å pore size, 250 
10-mm (Phenomenex)) and a gradient from 5 to 50% acetoni-
trile (0.1% TFA) over 50 min at a rate of 1.5 ml/min. Correct
masses were verified by electrospray mass spectrometry. The
following peptideswere synthesized as amidated and acetylated
and generally contained N- and C-capping motifs (underlined)
for improved helix stability and solubility: c-Jun ASIARLEEK-
VKTLKAQNYELASTANMLREQVAQLGAP; c-Fos ASTDT-
LQAETDQLEDEKYALQTEIANLLKEKEKLGAP; FosW ASL-
DELQAEIEQLEERNYALRKEIEDLQKQLEKLGAP; 4hFosW
ASLDELQREIEQLEELNYALQKEIEDLQKQGAP; basic c-Jun
RIKAERKRMRNRIAASKCRKRKLERIARLEEKVKTLKAQN-
YELASTANMLREQVAQLGAP; and basic c-Fos EEKRRIRRE-
RNKMAAAKCRNRRRELTDTLQAETDQLDEKYALQTEIA-
NLLKEKEKLGAP. Peptide concentrationswere determined by
FIGURE 1. Helical wheel representation and peptide sequence comparison. A, helical wheel representation highlighting the interaction patterns for the
FosW-c-Jun and 4hFosW-c-Jun heterodimers. Residues for FosW (left) and c-Jun (right) are colored black. Library options for the 4hFosW library that differ from
theFosWtemplate are shown ingray. Residuespresent in FosWthathavebeen truncated in4hFosWare shown inparentheses. LibrarydesignandPCAselection
(circled) residues in the 49,152 member 4hFosW library are also shown. B represents a linear arrangement of the interacting helices, as well as the position of
residueswithin the 4.5 (c-Jun and FosW) or 4 (4hFosW) heptads of the individual helices. The arrows indicate potentialg/e interactions between the helices in
the heterodimer. The three library selected positions of 4hFosW that differ fromFosWare underlined. These are Ala to Arg at f1, Arg to Leu atg2, andArg toGln
at e3. Also shown are N- and C-terminal capping motifs to aid helix stability.
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weighing and were confirmed in water using the absorbance at
280 nm with an extinction coefficient of 1209 M1 cm1 (17)
corresponding to a Tyr residue inserted into a solvent-exposed
b3 heptad position.
Circular Dichroism—Circular dichroism (CD) was carried
out using an Applied Photophysics Chirascan CD apparatus
(Leatherhead, UK) using a 200-l sample in a CD cell with a
1-mmpath length. Samples contained 150M total peptide (Pt)
concentration suspended in 10 mM potassium phosphate and
100 mM potassium fluoride at pH 7. The CD spectra of the
homodimeric c-Jun and 4hFosW complexes and the heterodi-
meric complex were scanned between 300 and 190 nm at 20 °C
(for both pre- and postmelt samples) and at 8 °C to assess
helical levels and coiled coil structure (see Fig. 2). All data have
been converted from raw ellipticity to molar residue ellipticity
according to Equation 1,
MRE

10 l r c
(Eq. 1)
where  is the CD signal of the sample in millidegrees; l is the
path length of the cell in centimeters; r is the number of residues
in the peptide; and c is the total peptide concentration of the
sample in molar.
Thermal Melts—Spectra and thermal melts were per-
formed at 150 M Pt in 10 mM potassium phosphate, 100 mM
potassium fluoride, pH 7, using an Applied Photophysics
Chirascan CD instrument (Leatherhead, UK). The tempera-
ture ramp was set to stepping mode using 1 °C increments
and paused for 30 s at each temperature before measuring
ellipticity at 222 nm. For all temperature denaturation
experiments, data collection was started at8 °C, and at this
temperature, the peptide solutions remained aqueous. Data
points for thermal denaturation profiles represent the aver-
aged signal after 4 s of data collection. Samples were identi-
cal in composition to the CD buffer samples. Melting profiles
(see Fig. 3) were 95% reversible with equilibrium denatur-
ation curves fitted to a two-state model, derived via modifi-
cation of the Gibbs-Helmholtz equation (18, 19), to yield the
melting temperature (Tm) (Equation 2).
G  H  TA/Tm  H  R  Tm  ln(Pt)
 Cp TA Tm TA ln(TA/Tm) (Eq. 2)
where H is the change in enthalpy; TA is the reference tem-
perature in kelvin; R is the ideal gas constant (1.9872
calmol1K1); Pt the total peptide concentration (150 M);
and Cp the change in heat capacity. Melting profiles for het-
erodimers are clearly distinct from averages of constituent
homodimeric melts (shown in Fig. 3 and via dimer exchange in
Fig. 4), indicating that helices are heterodimerizing. The coop-
erative nature of themelting profiles suggests an apparent two-
state process. Tm values were determined by least squares fit-
ting of the denaturation assuming a two-state folding model
that is widely used for coiled coils (19) and provided an excel-
lent fit to our data.
ITC Measurements—ITC measurements were made using a
MicroCal VP-ITC instrument with data collected and pro-
cessed using the Origin 7.0 software package. All measure-
ments were carried out at least two times. Briefly, all peptides
FIGURE 2. CD spectra of 4hFosW homodimeric (A) and 4hFosW-c-Jun heterodimeric (B) complexes. Peaks at 222 and 208 nm are indicative of a helical
structure with the 222/208 ratio providing evidence for the formation of a coiled coil structure (see Table 1). Overlapping of the spectra at 20 °C in both cases
shows the structure is able to reconstitute following thermal denaturation. Increased stability of the structure at8 °C is consistent with further stabilization
at lower temperatures. The greatermagnitude of the peak at 222 nm in the heterodimeric complex (B) (approximately112millidegrees) comparedwith the
homodimeric complex (A) (approximately87millidegrees) at 20 °C suggests that the heterodimeric complex is more stable than the homodimeric 4hFosW
and that 4hFosW will preferentially form a heterodimer with c-Jun.
FIGURE 3. Thermal denaturation profiles. Denaturation profiles for
homodimeric c-Jun (closed circles) as well as 4hFosW (closed triangles) and
c-Jun-4hFosW (open squares) are shown (see also Table 1). All experiments
were undertaken in 10mMpotassiumphosphate, 100mMpotassium fluoride
at pH 7. The total peptide concentration for all experimentswas 150M. Data
were fitted to the two-state model (Equation 2). FU, fraction unfolded.
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were studied at 20 °C in 10 mM potassium phosphate and 100
mM potassium fluoride at pH 7. 600 l of peptide 1 was loaded
into the syringe at between 175 and 250 M peptide concentra-
tion. 1800l of peptide 2 was loaded into the cell at 10–40M.
The peptide in the syringe and cell was reversed to check that
the results were unaffected by this change. The experiment was
undertaken by injecting 5 l 25 injections of peptide 1 into
the calorimetric cell. The change in thermal power as a function
of each injection was automatically recorded using the Micro-
Cal Origin software (20), and the raw data were integrated to
yield ITC isotherms of heat release per injection as a function of
Fos to Jun molar ratio. In general, the concentration of peptide
2 loaded into the cell was 30 times the anticipated protein-
protein interactionKD value, and the concentration of peptide 1
in the syringe was at least 20 times the concentration of peptide
2. No precipitation of protein was observed in any of the exper-
iments undertaken. Following ITC measurements, the data
were fit to a one-site model (Equation 3),
qi  nHVP/ 21  L/nP  Kd/nP
 1  L/nP  Kd/nP
2  4L/nP1/ 2 (Eq. 3)
where q(i) is the heat release (kcal/mol) for the ith injection; n is
the stoichiometry of heterodimerization; V is the effective vol-
ume of protein sample loaded into the calorimetric cell (1.46
ml); P is the total Jun concentration in the calorimetric cell (in
micromolars), and L is the total Fos concentration in the calo-
rimetric cell at the end of each injection (in micromolars). This
model is derived from the binding of a ligand to a macromole-
cule using the law of mass action (assuming a 1:1 stoichiometry
of 4hFosW to c-Jun) to extract the various thermodynamic
parameters (20, 21), namely the apparent equilibrium constant
(Kd) and the enthalpy change (H) associated with het-
erodimerization. By iteratively fitting the binding isotherms to
the above, one is able to generate values forKd andH. The free
energy change (Gbind) upon ligand binding can then be calcu-
lated from the relationship shown in Equation 4,
Gbind  RTLnKD (Eq. 4)
where R is the universal molar gas constant (1.9872
calK1mol1); T is the absolute temperature in kelvin (293.15
K); and KD is the dissociation constant of binding with units of
molliter1. Finally, the entropic contribution (TS) to the free
energy of binding was calculated using the derived values ofH
and Gbind.
Electrophoretic Mobility Shift Assay (EMSA)—Pure basic
c-Jun and basic c-Fos proteins were mixed at a ratio of 1:1 with
70 M of each protein and either the presence or absence of a
1:2 or 1:7molar ratio of 4hFosWbefore being added to 100ng of
DNA (14 M) containing the AP-1 TRE consensus sequence
(5-CGCTTGATGACTCAGCCGGAA-3). Protein-DNA
samples were then incubated on ice for 30 min in 1 binding
buffer (700 mM KCl, 2.5 mM DTT, 2 mM EDTA, 25 mM Tris-
HCl, 10 mMMgCl2, and 2% glycerol). The samples were run on
a 6.5% TBE nondenaturing polyacrylamide gel in 0.5 TBE
buffer before being stained with SYBR Green for 30 min to
stain forDNA and imaged on a transilluminator followed by 3 h
of staining with SYPRO Ruby followed by destaining and
imaging on a transilluminator tomonitor for the colocalization
of DNA and protein in shifted bands.
FIGURE 4. ITC analysis of leucine zipper domain interactions between c-Jun and c-Fos (A) aswell as the interaction of c-Junwith FosW (B) and 4hFosW
(C) antagonists. The top and bottom panels show raw data after base-line correction. During ITC experiments, 	200–600 M peptide A was injected in
30–40 5-l batches from the injection syringe into the cell, which contained 10–40 M of peptide B. Both partners were in a 10 mM potassium phosphate
buffer, 100 mM potassium fluoride at pH 7. Experiments were undertaken at 20 °C. The solid lines represent the fit of the data to the function based on the
binding of a ligand to a macromolecule using the MicroCal (GE Healthcare) Origin software (20).
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Free Energy Changes from the Literature—Calculated differ-
ences between coiled coil values at 37 °C (Table 3) have been
previously reported in Krylov et al. (22) for electrostatic gi 
ei
1 and ei
1  gi contributions and Acharya et al. (7) for
hydrophobic a-a contributions. In these publications, free
energies were calculated relative to Ala-Ala pairs. It should be
noted that these values have been averaged from the data
reported for g/ei
1 and ei
/g.
RESULTS
We have previously derived a range of peptides capable of
binding to c-Jun (13, 15, 23). c-Jun is a particularly interesting
target because sequestering it will release the Fos homologue,
withwhich it predominantly heterodimerizes. Fosmembers are
thought to be unable to homodimerize in vivo and are therefore
less likely to give rise to an oncogenic phenotype (24). All pre-
vious peptide antagonists have been 37 residues in length, con-
sisting of 4.5 heptads (32 residues) and flanked by anN-capping
and a C-capping motif. We are now seeking to reduce the
length and molecular weight of our derived antagonists while
retaining a suitably high free energy of binding to the target
peptide. The c-Jun target has been kept at 37 residues as this
incorporates the entire coiled coil region of the peptide and
therefore represents the target zipper as it would be found in
vivo. Consequently, truncation of c-Jun would unnecessarily
destabilize the interaction with the antagonist. Here, we
describe the truncation of four amino acids from the C termi-
nus of the FosW peptide (while retaining the C-capping motif;
see Fig. 1) followed by a re-randomization of key positions
within the 33-residue 4hFosW library peptide scaffold. Shown
in Fig. 1A is the FosW and 4hFosWhelix as would be found in a
coiled coil interaction with c-Jun. The four truncated residues
in FosW are shown in Fig. 1A in parentheses. Fig. 1B displays
complete sequence alignments and includes capping motifs
and predicted e-g interactions.
4hFosWLibraryRandomization—Library designwas through a
semi-rational approach, because of the need to explore residue
selections that may enhance affinity, while maintaining the
library to a manageable size and sampling useful space where
possible. LZ residue preferences have been widely explored
with regard to inter-helical contacts (7, 10), and helical propen-
sity scales have been developed to allow structural prediction
(25, 26), which allow libraries to be developed to test the trade
offs of different factors in coiled coil stability. Through this
approach, the Arg residue at position g2was randomized using
the codon vkh to give options of Leu, Ile, Val, Arg, Ser, and Gly,
which is a library including long chain hydrophobic Leu, Ile,
and Val residues while retaining the Arg option in the parent
molecule (and consequentially including the unfavorable Ser
and Gly residues, which were not expected to be selected). Leu,
Ile, andValwere specifically included to test for a preference for
long chain hydrophobic residues situated to interact with the
adjacent Ala residue at e3 and would also be predicted to pack
into the hydrophobic pocket formed by the ethyl groups of
adjacent e2 and e4Glu residues. Positions f1 and c3 have been
randomized using the codon ssn to generate Ala, Arg, Gly, and
Pro options. Inclusion of Ala generates the possibility of retain-
ing high levels of helicity, although Arg is a logical option given
the negative charge on residues that flank both of these posi-
tions. Inclusion of Gly/Pro is a by-product of Ala/Arg options
but would be predicted to be helix-destabilizing and therefore
not favored at these positions. Finally, positions g1, e3, and e4
were randomized using the codon svm to generate options for
Arg, Glu, Ala, Pro, Gly, Asp, His, and Gln options at these typ-
ically electrostatic positions. This codon therefore generates
both positively charged (Arg), negatively charged (Glu/Asp),
and polar (Gln) electrostatic options, helical options (Ala) as
well as His and the Gly/Pro that would not be predicted to be
selected.
4hFosW Library Selection—Following construction of the
libraries, single step PCA was undertaken followed by sequen-
tial liquid growths. This process identified a single sequence by
the 5th passage of liquid growth competition. Of the six ran-
domizations described above, we observed that three positions
(g1, c3, and e4) re-selected the same residue found in the FosW
parent peptide. For position e4, Gln arose from a smaller subset
of options at this position in the selection of the original FosW
peptide (13) demonstrating that the original selection is also
favored over an extended range of residues in this library. The
remaining three positions, f1, g2, and e3, constituted Ala 3
Arg, Arg3 Leu, and Arg3 Gln selections, respectively. The
first of these changes occurs at a solvent-exposed position. Ala
at this position is flanked by Asp andGlu at positions b1 and c1
as well as Glu at position f2 of the next heptad, and so a prefer-
ence for this change would be anticipated to improve intrahe-
lical interactions within the 4hFosW helix and therefore the
stability of the coiled coil complex. The second of these changes
occurs at a g2position that has the potential tomake a favorable
interaction with e3 residue on the c-Jun target helix. In this
target helix, these positions are usually occupied by a polar res-
idue of opposite charge to facilitate favorable electrostatic
interactions. Because Ala occupies this position in c-Jun, the
Arg option present in FosWwas includedwith Leu, Ile, andVal,
options additionally included to generate branched hydropho-
bic options that can make contact with the short Ala side chain
and generate a favorable hydrophobic interaction. This hydro-
phobic association is then able to assist with desolvation of the
core residues and perhaps providing a favorable a-g interac-
tion, a contributory factor that has been speculated to play a
role in specificity determination (27). The last of the three
changes from the FosW parent peptide is an Arg to Gln change
found at position e3,which is predicted to interactwith another
Gln at position g2 of c-Jun. For this electrostatic interaction,
the contribution to the free energy of binding has been experi-
mentally determined and is predicted to be 0.5 kcal/mol more
stable for Gln-Gln (1.2 kcal/mol) than Arg-Gln (0.7 kcal/
mol) (22).
Circular Dichroism Experiments—CD spectra taken of both
4hFosW in isolation and in heterodimeric formwith c-Jun indi-
cate the presence of a coiled coil structure. Minima are present
at 222 and 208 nm, indicating the presence of a helical struc-
ture, and in particular, the ratio between these two values is
	1.0 (see Table 1). Typically a value of less than 0.9 indicates
the presence of an 	-helix in isolation, as is found with c-Jun-
c-Fos, which is found as amixture of coiled coil andmonomeric
helices at values close to this temperature (28, 29). Indeed, ther-
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mal melt analysis indicates that this coiled coil containing
dimerization region for the wild-type c-Jun-c-Fos has a Tm of
16 °C (homodimeric c-Jun Tm  24 °C) (13). In contrast,
homodimeric 4hFosW displays a Tm of 36 °C. Thus, the
observed Tm of 49 °C for the designed c-Jun4hFosW complex
far exceeds the average of the c-Jun and 4hFosW constituent
homodimeric melts that would be predicted if no heterodi-
meric interaction were observed ((24 °C
 36 °C)/2 30 °C).
Predicted and Measured Helicity—The PCA winner
sequence is predicted to give a Tm of 32 °C according to bCIPA
(13). This rather large underestimation in stability may stem
from a stronger helical component than bCIPA calculates
based on the propensity scale ofWilliams et al. (26). Indeed, all
helical predictors consider helices in isolation and do not
account for increases attributable to intermolecular interac-
tions. The best example of this is for c-Jun(Arg)-FosW(Glu),
which have both modest predicted and measured helicities in
isolation, but when mixed are hugely stabilized by a favorable
Glu-Arg electrostatic complement (11). This gives rise to a
measured fractional helicity of 0.88 but would be predicted to
have a low helical content if this calculation wasmade based on
averaged individual helices. bCIPA reports a negligible loss in
electrostatic contribution and a 25% loss in the hydrophobic
contribution. This is attributable to the loss of a5 and d5 inter-
actions but almost no loss in the helicity of the truncated inter-
action. Measured helicity based on 222 in this study indicated
that c-Jun-4hFosW is 60.4% helical compared with 35.8% for
c-Jun-FosW (see Table 1). Indeed, despite truncation, 4hFosW
is actually more helical than FosW (50.6 versus 43.7%).
Dimer Exchange Experiments—In an experiment to verify the
interaction between 4hFosW and c-Jun, we performed a dimer
exchange experiment (see Fig. 5). In the first of two experi-
ments, the spectra for the c-Fosc-Fos homodimeric complex
(Fig. 5A, closed circles, Tm 1 °C) and c-Jun-4hFosW (open
squares, Tm 49 °C) were recorded using 200 l of sample at 150
M total peptide concentration. Next, 100 l of each solution
was mixed, and the spectra were taken such that the final total
peptide concentration was also 150 M. In this case, the
observed spectra (Fig. 5A, closed triangles) exactly matched
the average of the previous two spectra, indicating that no
exchange of dimer has occurred. This experiment therefore
indicates that 4hFosW retains preference for c-Jun and that
c-Fos is consequently left remaining in its homodimeric
form. In the second experiment (see Fig. 5B), c-Jun-c-Jun
(closed circles, Tm 24 °C) is mixed with c-Fos-4hFosW (open
squares) such that the final composition of the mixed solu-
tion is identical to that of the previous experiment. Thus, as
predicted, the helices exchange such that 4hFosW binds to
c-Jun and the c-Fos peptide is free to homodimerize. There-
fore a large increase in spectra magnitude over the average of
the two premixed samples is observed (Fig. 5B, closed trian-
gles). Finally, it is shown (Fig. 5C) that the spectra for both
postmixed samples superimpose, signifying that the same
species is being populated in both samples. Collectively, this
experiment indicates that 4hFosW binds and sequesters the
c-Jun peptide from c-Fos and in doing so is specific for c-Jun
in the presence of c-Fos.
Isothermal Titration Calorimetry Experiments—To provide
a second measure of the binding affinity (KB) between target
and antagonist, ITC experiments were undertaken. This addi-
tionally permitted the free energy of binding to be split into
its entropic and enthalpic components as well as providing a
guide on the stoichiometry of binding. The KB values are in
reasonable agreement with those derived from the thermal
melting data. It appears, however, that c-Jun-4hFosW has a
greater enthalpic contribution to the binding energy relative
to c-Jun-FosW (30), but this is more strongly opposed by the
entropic term. This is perhaps due to the fact that although
the chain has become more ordered (as is evident from
increased measured helicity) and that this may contribute to
a moderately more favorable enthalpy of binding, it is not
matched by improved desolvational entropy. Thus, overall,
the c-Jun-4hFosW is around 1 kcal/mol less stable than
c-Jun-FosW.
Growth Competition Experiments—Under selective condi-
tions, Escherichia coli growth rates for cells containing either (i)
c-Jun-c-Fos, (ii) c-Jun-FosW, or (iii) c-Jun-4hFosWwere mon-
itored under PCA conditions in M9 minimal media containing
ampicillin, chloramphenicol, kanamycin, trimethoprim (for
bacterial inhibition of DHFR), and isopropyl -D-1-thiogalac-
TABLE 1
Thermodynamic data from thermal melt analysis, ITC, and 222/208 ratios andmeasured helicity taken from CD spectra
The helicity of c-Jun, FosW, and 4hFosW in isolation is calculated to be 12.9, 43.7, and 50.6%, respectively. Tm has been estimated from a fit to thermal melting data using
Equation 2, from which values for KD and Gbind(Thermal) were obtained. ITC data were obtained at 20 °C with a MicroCal VP-ITC using a fit to Equation 3. The 222/208
ratios provide information on the likelihood of the 	-helix being in isolation or found within a coiled coil structure (28, 29, 47). A ratio greater than 1.0 typically indicates
the latter, and a ratio of approximately 0.9 or less indicates the presence of a helix in isolation. With the exception of c-Jun-c-Fos, both c-Jun-antagonist interactions are
greater than 0.9, thus supporting the formation of a coiled coil structure. Fraction helicity (fH) can be calculated as fH (222 qc)/(222∞ qc), where 222∞ (44,000

250T)(1 k/Nr) and c 2220 (53T). In these equations, the wavelength-dependent constant k 2.4 (at 222 nm),Nr the number of residues, and T 20 °C (293 K).
Agadir (48, 49) severely underestimates helicity formany of the dimeric pairs, most likely because it does not take into account that interhelical interactions assist with helix
integrity in the dimeric pairs; it only considers the helicity of individual helices in isolation. Thus, the measured helicity is often higher than the values predicted from the
average of the two constituent helices by Agadir.
c-Jun-c-Fos c-Jun-FosW c-Jun-4hFosW
Tm 16 63 49
KD (thermal) 26.6 M 45 nM 487 nM
Gbind (thermal) 5.5 kcal/mol 11.4 kcal/mol 8.5 kcal/mol
N 1.1 0.01 0.65 0.01 1.05 0.01
KB(20 °C) M 1 (ITC) 3.8e4 2.5e4 2.2e7 4.3e6 2.1e6 2.0e5
Gbind (ITC) 6.1 0.4 kcal/mol 9.9 0.1 kcal/mol 8.8 0.1 kcal/mol
H 0.8 0.4 kcal/mol 10.6 0.2 kcal/mol 14.1 0.2 kcal/mol
TS (H G) 5.3 0.5 kcal/mol 0.7 0.2 kcal/mol 5.3 0.2 kcal/mol
222/208 (20 °C) 0.75 1.0 0.99
Fraction helical (fH) 3.6% 35.8% 60.4%
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topyranoside (to induce protein expression). This experiment
was carried outwith c-Jun expressed on the pES300dplasmid as
a DHFR2 fragment fusion and the Fos peptide expressed on the
pES230d plasmid as a DHFR1 fragment fusion (see Fig. 6).
Thus, E. coli growth rates are dictated by the binding affinity of
the two expressed helices. The higher the affinity, the greater
the DHFR activity and the faster cells are able to grow. In broad
agreement with thermal melting studies (Fig. 3), ITC experi-
ments (Fig. 4), and dimer exchange studies (Fig. 5), we observe
that FosW and 4hFosW both bind c-Jun with much improved
affinity over c-Fos, such that the order of fastest growth is
c-Jun-FosW	 c-Jun-4hFosW c-Jun-c-Fos.
Electrophoretic Mobility Shift Assay—Finally, EMSA was
undertaken using an assay kit (Invitrogen) that contained two
fluorescent dyes to stain sequentially for the presence of DNA
(SYBR Green) and protein (SYPRO Ruby). Using this tech-
nique, shifts in DNA could be correlated to the presence of
AP-1 protein bands, thus verifying that the protein and DNA
are contained within the same shifted band. EMSAs were per-
formed to demonstrate that 4hFosW cannot only prevent
dimerization of the leucine zipper regions of c-Jun but can also
antagonize the DNA binding ability of the c-Jun/c-Fos AP-1
protein by sequestering c-Jun. In this experiment, AP-1 consist-
ing of equimolar amounts of basic c-Jun and basic c-Fos was
mixed with DNA containing the TPA-response element, either
in the absence or presence of 1:2 or 1:7 molar ratios of 4hFosW
(see Fig. 7). In the absence of 4hFosW, DNA binding is clearly
demonstrated by a loss of intensity relative to the free DNA
FIGURE 6. Bacterial growth data for E. coli BL21 Gold expressing c-Jun-
DHFR2 (CmR) and pREP4 (KanR) for lac repression and either c-Fos-DHFR1,
FosW-DHFR1, or 4hFosW-DHFR1 (AmpR).Cells were grownunder PCA condi-
tions to monitor growth mediated by DHFR reconstitution as a function of the
formation of the interacting dimers. Thus, more rapid growth is indicative of a
higher interaction affinity between the Fos-DHFR1 constructs and c-Jun-DHFR2
construct. Starting cultures were grown overnight in M9 media, inoculated in
duplicatetoA6000.01,andgrown.Growthwasmonitoredhourlybymeasuring
the A600. The rapid rate of growth for the 4hFosW-c-Jun (open triangles) and
FosW-c-Jun (open squares) cultures relative to the c-Fos-c-Jun (closed circles) indi-
cates a high interaction affinity relative to the native complex, suggesting that
despite the loss of somehydrophobic core residues, this does not greatly dimin-
ish interaction affinity. The result supports thermal melting and ITC data in sug-
gesting that these interactions are of higher affinity than the native c-Fos-c-Jun
interaction,whichdisplaysanextendedgrowthperiod indicatinga loweraffinity
interaction. This result suggests that 4hFosW would displace c-Fos from the
c-Fos-c-Jun complex due to having higher affinity for c-Jun, as is observed in the
dimer exchange assays and EMSA experiments.
FIGURE 5. Circular dichroism dimer exchange experiments. A, homodimeric c-Jun mixed with c-Fos-4hFosW clearly causes dimer exchange to give rise to
spectra that not only far exceed the average of the two components but that is more helical than either dimer. B, c-Fos is mixed with c-Jun-4hFosW, and the
averaged spectra are exactly what is observed, indicating that no helix exchange occurs. C,we observe that themixed spectra in both A and B are completely
superimposable, indicating that the same species is being populated in both instances. In all experiments, Pt is held constant at 150 M.
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band (Fig. 7, 1st lane) and by the observed migration of the
proteinDNA complex (2nd lane). However, in the presence
of 4hFosW, DNA binding is significantly reduced as can be
observed by a decrease in intensity of the migrated
DNAprotein complex (Fig. 7, 3rd and 4th lanes) and an
increase in intensity of the nonshifted free DNA relative that
is similar to DNA in isolation.
DISCUSSION
The concept of peptides and their mimetics as the starting
point as druggable agents is an area of growing interest in the
pharmaceutical industry (31–33). One of the main issues that
has traditionally dampened the appeal has been the size of the
molecule and consequent implications associated with peptide
drugs. In particular, it was thought that molecules of greater
than 	500 Da would hamper potential efficacy during clinical
trials. In contrast, smallmolecules thatmet the required criteria
at the preclinical stagewould have a higher likelihood of success
at later more involved stages and would therefore be a safer
investment as a starting point for research. In particular,
because of their size, many peptides are unable to traverse
membranes. They can also be susceptible to proteases and can
be quickly eliminated from the body. Although these last two
problems can potentially be addressed via increasingly viable
nonpeptidic modification of the chain, the first is intrinsic.
More recently, techniques such as conjugation to a “protein
transduction domain” to form “cell-penetrating peptides” (34,
35), production of stabilized “cyclic peptides” (36, 37), creation
of “retro-inverso peptides” (38), or introduction of hydrocar-
bon staples (39–41) into peptide backbones have all been
attempted to circumvent these problems. Therefore the poten-
tial of peptide therapeutics is now a growing area, with peptides
harboring the potential for chemical and biological diversity
while maintaining high specificity and affinity for a protein
target.
In our own studies, we are undergoing iterations of produc-
ing increasingly smaller peptides that are able to bind to AP-1
components via their coiled coil region and antagonize their
natural function. We ultimately seek to identify the smallest
functional region and further investigate and develop its thera-
peutic value. To this end, we have applied one iteration of
“Truncation, Randomization, and Selection” (TRaSe). Previ-
ously selected peptides were 37 residues in length and therefore
comparable in size to commercially available peptide-based
drugs such as enfuvirtide (42), which is administered for
patients suffering from multidrug-resistant forms of HIV.
However, in the interest of identifying the smallest region
required for efficient binding to c-Jun, we truncated the previ-
ously selected FosW by four residues at the C-terminal end.
This culminated in the loss of one a and one d residue from the
core region of the fifth heptad in the coiled coil interaction (see
Fig. 1). This represents a loss of	11%of the parent peptide, and
it is worthy of note that even the smallest designed coiled coil
was 15 residues in length, equating to two heptad repeats (43).
In that case, both helices in the coiled coil interaction were free
to be modified to maximize binding affinity. However, design-
ing coiled coils that deviate from peptide-Velcro theory of pro-
tein design (44), whereby the target helix cannot be modified,
presents numerous obstacles in truncating the antagonizing
FIGURE 7. EMSA demonstrates that 4hFosW is able to prevent AP-1 from binding to the TRE consensus sequence. Left panel, gel, stained with
SYBR Green to detect DNA, shows TRE-DNA in isolation (1st lane), with the addition of the wild-type basic c-Junbasic c-Fos AP-1 complex in the
presence of DNA corresponding to a shift in the observed DNA band (2nd lane). Upon addition of 4hFosW at either 1:2 or 1:7 molar ratio (3rd and 4th
lanes), the amount of observed free DNA relative to the 2nd lane is increased. Right panel, when the same gel is stained for protein using SYPRO Ruby,
no protein is observed in the 1st lane, whereas the co-localized DNA-protein complex is observed in the 2nd lane. Upon addition of 4hFosW at 1:2 (3rd
lane) or 1:7 molar ratio (4th lane), the intensity of the free stained DNA in A is seen to increase. Moreover, at the increasedmolar ratio of 1:7, the intensity
of the protein stained DNAprotein complex is significantly lower, demonstrating that 4hFosW has an inhibitory effect on the DNA binding ability of
AP-1.
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helix while maintaining interaction stability, because only one
half of the interaction can be optimized. Consequently, we have
used the TRaSe strategy to partially randomize key residues at
and away from the interface and which offer the potential for
further improvement of the chain in binding to c-Jun. TheTm
between c-Jun-FosW and the c-Jun-4hFosW interaction is only
14 °C (see Table 1) despite the loss of the a5/d5 hydrophobic
residues from the chain. Strikingly, inspection of the mea-
sured helicity by CD demonstrates that c-Jun-4hFosW is
almost 25% more helical than c-Jun-FosW despite the loss of
these four C-terminal residues. Of the three changes made to
the chain, it is most likely that improved helicity is the result
of two changes; the Ala to Arg mutation at position f1 results
in improved intramolecular electrostatic interactions with
flanking Glu/Asp residues, and the Arg to Leumutation at g2
results in a branched hydrophobic residue capable of form-
ing an intermolecular interaction with Ala on the flanking
c-Jun helix by generating a favorable hydrophobic interac-
tion and assisting with desolvation of buried core residues.
Consistent with this, additional helicity and stability com-
pensating for the loss in truncation is that 4hFosW is also
marginally more helical in isolation (	7%) relative to FosW.
The 4hFosW peptide demonstrates that leucine zipper pep-
tides of reduced length relative to the target region are able
to inhibit functional complexes formed by the target upon
interaction in full-length parent molecules. Thus, it is shown
here that truncated leucine zippers as opposed to full-length
zippers (13), acidic zippers (45), or c-Jun lacking the trans-
activation domain (27) are able to bind to c-Jun and inhibit
the DNA binding activity of AP-1, as has been demonstrated
by EMSA. In addition, the ITC results demonstrate that the
TRaSe strategy has optimized the enthalpy of binding
despite a decrease in antagonist size. Optimizing for favor-
able enthalpy has been described as the key parameter in lead
compound design, but its optimization during lead discovery
is considered difficult because of the correct engineering of
correct bond angles and lengths (46).
These results show that by using intelligent options during
the semirational design process, it may in the future be possible
to apply additional iterations of TRaSe to further reduce the
size of our antagonists while gaining added insight into the
smallest known functional region required to generate an
interaction.
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